376 related articles for article (PubMed ID: 27117591)
1. Novel patient-derived xenograft and cell line models for therapeutic testing of pediatric liver cancer.
Bissig-Choisat B; Kettlun-Leyton C; Legras XD; Zorman B; Barzi M; Chen LL; Amin MD; Huang YH; Pautler RG; Hampton OA; Prakash MM; Yang D; Borowiak M; Muzny D; Doddapaneni HV; Hu J; Shi Y; Gaber MW; Hicks MJ; Thompson PA; Lu Y; Mills GB; Finegold M; Goss JA; Parsons DW; Vasudevan SA; Sumazin P; López-Terrada D; Bissig KD
J Hepatol; 2016 Aug; 65(2):325-33. PubMed ID: 27117591
[TBL] [Abstract][Full Text] [Related]
2. Characterization of patient-derived tumor xenograft models of endometrial cancer for preclinical evaluation of targeted therapies.
Depreeuw J; Hermans E; Schrauwen S; Annibali D; Coenegrachts L; Thomas D; Luyckx M; Gutierrez-Roelens I; Debruyne D; Konings K; Moerman P; Vergote I; Lambrechts D; Amant F
Gynecol Oncol; 2015 Oct; 139(1):118-26. PubMed ID: 26232337
[TBL] [Abstract][Full Text] [Related]
3. Establishment of a Patient-Derived Xenograft Tumor From Hepatitis C-Associated Liver Cancer and Evaluation of Imatinib Treatment Efficacy.
Nazzal M; Sur S; Steele R; Khatun M; Patra T; Phillips N; Long J; Ray R; Ray RB
Hepatology; 2020 Aug; 72(2):379-388. PubMed ID: 32356575
[TBL] [Abstract][Full Text] [Related]
4. A novel patient-derived orthotopic xenograft model of esophageal adenocarcinoma provides a platform for translational discoveries.
Veeranki OL; Tong Z; Mejia A; Verma A; Katkhuda R; Bassett R; Kim TB; Wang J; Lang W; Mino B; Solis L; Kingsley C; Norton W; Tailor R; Wu JY; Krishnan S; Lin SH; Blum M; Hofstetter W; Ajani J; Kopetz S; Maru D
Dis Model Mech; 2019 Dec; 12(12):. PubMed ID: 31732509
[TBL] [Abstract][Full Text] [Related]
5. Colorectal cancer patient-derived xenografted tumors maintain characteristic features of the original tumors.
Cho YB; Hong HK; Choi YL; Oh E; Joo KM; Jin J; Nam DH; Ko YH; Lee WY
J Surg Res; 2014 Apr; 187(2):502-9. PubMed ID: 24332554
[TBL] [Abstract][Full Text] [Related]
6. A Novel Cell Line Based Orthotopic Xenograft Mouse Model That Recapitulates Human Hepatoblastoma.
Woodfield SE; Shi Y; Patel RH; Jin J; Major A; Sarabia SF; Starosolski Z; Zorman B; Gupta SS; Chen Z; Ibarra AM; Bissig KD; Ghaghada KB; Sumazin P; López-Terrada D; Vasudevan SA
Sci Rep; 2017 Dec; 7(1):17751. PubMed ID: 29259231
[TBL] [Abstract][Full Text] [Related]
7. Characterizing the efficacy of cancer therapeutics in patient-derived xenograft models of metastatic breast cancer.
Turner TH; Alzubi MA; Sohal SS; Olex AL; Dozmorov MG; Harrell JC
Breast Cancer Res Treat; 2018 Jul; 170(2):221-234. PubMed ID: 29532339
[TBL] [Abstract][Full Text] [Related]
8. Establishment of an orthotopic patient-derived xenograft mouse model using uveal melanoma hepatic metastasis.
Kageyama K; Ohara M; Saito K; Ozaki S; Terai M; Mastrangelo MJ; Fortina P; Aplin AE; Sato T
J Transl Med; 2017 Jun; 15(1):145. PubMed ID: 28645290
[TBL] [Abstract][Full Text] [Related]
9. Application of patient-derived liver cancer cells for phenotypic characterization and therapeutic target identification.
Castven D; Becker D; Czauderna C; Wilhelm D; Andersen JB; Strand S; Hartmann M; Heilmann-Heimbach S; Roth W; Hartmann N; Straub BK; Mahn FL; Franck S; Pereira S; Haupts A; Vogel A; Wörns MA; Weinmann A; Heinrich S; Lang H; Thorgeirsson SS; Galle PR; Marquardt JU
Int J Cancer; 2019 Jun; 144(11):2782-2794. PubMed ID: 30485423
[TBL] [Abstract][Full Text] [Related]
10. Patient-derived mouse xenografts from pediatric liver cancer predict tumor recurrence and advise clinical management.
Nicolle D; Fabre M; Simon-Coma M; Gorse A; Kappler R; Nonell L; Mallo M; Haidar H; Déas O; Mussini C; Guettier C; Redon MJ; Brugières L; Ghigna MR; Fadel E; Galmiche-Rolland L; Chardot C; Judde JG; Armengol C; Branchereau S; Cairo S
Hepatology; 2016 Oct; 64(4):1121-35. PubMed ID: 27115099
[TBL] [Abstract][Full Text] [Related]
11. Molecular heterogeneity of non-small cell lung carcinoma patient-derived xenografts closely reflect their primary tumors.
Wang D; Pham NA; Tong J; Sakashita S; Allo G; Kim L; Yanagawa N; Raghavan V; Wei Y; To C; Trinh QM; Starmans MH; Chan-Seng-Yue MA; Chadwick D; Li L; Zhu CQ; Liu N; Li M; Lee S; Ignatchenko V; Strumpf D; Taylor P; Moghal N; Liu G; Boutros PC; Kislinger T; Pintilie M; Jurisica I; Shepherd FA; McPherson JD; Muthuswamy L; Moran MF; Tsao MS
Int J Cancer; 2017 Feb; 140(3):662-673. PubMed ID: 27750381
[TBL] [Abstract][Full Text] [Related]
12. Microarray profiling shows distinct differences between primary tumors and commonly used preclinical models in hepatocellular carcinoma.
Wang W; Iyer NG; Tay HT; Wu Y; Lim TK; Zheng L; Song IC; Kwoh CK; Huynh H; Tan PO; Chow PK
BMC Cancer; 2015 Oct; 15():828. PubMed ID: 26520397
[TBL] [Abstract][Full Text] [Related]
13. Development and optimization of orthotopic liver metastasis xenograft mouse models in uveal melanoma.
Sugase T; Lam BQ; Danielson M; Terai M; Aplin AE; Gutkind JS; Sato T
J Transl Med; 2020 May; 18(1):208. PubMed ID: 32434572
[TBL] [Abstract][Full Text] [Related]
14. Novel patient-derived xenograft mouse model for pancreatic acinar cell carcinoma demonstrates single agent activity of oxaliplatin.
Hall JC; Marlow LA; Mathias AC; Dawson LK; Durham WF; Meshaw KA; Mullin RJ; Synnott AJ; Small DL; Krishna M; von Hoff D; Schüler J; Hart SN; Couch FJ; Colon-Otero G; Copland JA
J Transl Med; 2016 May; 14(1):129. PubMed ID: 27165126
[TBL] [Abstract][Full Text] [Related]
15. Histopathologic and immunophenotypic characterization of patient-derived pediatric malignant hepatocellular tumor xenografts (PDXs).
Patel KR; Espinoza AF; Urbicain M; Patel RH; Major A; Sarabia SF; Lopez-Terrada D; Vasudevan SA; Woodfield SE
Pathol Res Pract; 2024 Mar; 255():155163. PubMed ID: 38394806
[TBL] [Abstract][Full Text] [Related]
16. Establishment of a high-fidelity patient-derived xenograft model for cervical cancer enables the evaluation of patient's response to conventional and novel therapies.
Liu L; Wu M; Huang A; Gao C; Yang Y; Liu H; Jiang H; Yu L; Huang Y; Wang H
J Transl Med; 2023 Sep; 21(1):611. PubMed ID: 37689699
[TBL] [Abstract][Full Text] [Related]
17. Establishment of Patient-Derived Tumor Xenograft Models of High-Risk Endometrial Cancer.
Zhu M; Jia N; Nie Y; Chen J; Jiang Y; Lv T; Li Y; Yao L; Feng W
Int J Gynecol Cancer; 2018 Nov; 28(9):1812-1820. PubMed ID: 30358704
[TBL] [Abstract][Full Text] [Related]
18. Novel patient-derived preclinical models of liver cancer.
Bresnahan E; Ramadori P; Heikenwalder M; Zender L; Lujambio A
J Hepatol; 2020 Feb; 72(2):239-249. PubMed ID: 31954489
[TBL] [Abstract][Full Text] [Related]
19. Development of Patient Derived Xenograft Models of Overt Spontaneous Breast Cancer Metastasis: A Cautionary Note.
Paez-Ribes M; Man S; Xu P; Kerbel RS
PLoS One; 2016; 11(6):e0158034. PubMed ID: 27355476
[TBL] [Abstract][Full Text] [Related]
20. Patient-derived xenograft models of breast cancer and their predictive power.
Whittle JR; Lewis MT; Lindeman GJ; Visvader JE
Breast Cancer Res; 2015 Feb; 17(1):17. PubMed ID: 25849559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
